Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Sales | 2,073 | 1,457 | 2,306 | 2,009 | 1,264 |
| Cost of Goods | 225 | 151 | 432 | 260 | 264 |
| Gross Profit | 1,848 | 1,306 | 1,874 | 1,749 | 1,000 |
| Operating Expenses | 25,831 | 23,164 | 19,410 | 15,505 | 14,766 |
| Operating Income | -23,758 | -21,707 | -17,104 | -13,496 | -13,502 |
| Interest Expense | 132 | 307 | 12 | -4 | 25 |
| Other Income | -107 | 4,087 | -573 | 225 | -240 |
| Pre-tax Income | -23,997 | -17,927 | -17,689 | -13,267 | -13,767 |
| Income Tax | 0 | -1,120 | -948 | -1,271 | -1,177 |
| Net Income Continuous | -23,997 | -16,807 | -16,741 | -11,996 | -12,590 |
| Minority Interests | -6,885 | -3,300 | -3,115 | -2,305 | -2,423 |
| Net Income | $-17,112 | $-13,507 | $-13,626 | $-9,691 | $-10,167 |
| EPS Basic Total Ops | -0.19 | -0.16 | -0.18 | -0.12 | -0.13 |
| EPS Basic Continuous Ops | -0.27 | -0.20 | -0.21 | -0.15 | -0.16 |
| EPS Diluted Total Ops | -0.19 | -0.16 | -0.18 | -0.12 | -0.13 |
| EPS Diluted Continuous Ops | -0.27 | -0.20 | -0.21 | -0.15 | -0.16 |
| EBITDA(a) | $-21,950 | $-22,045 | $-13,694 | $-11,634 | $-11,857 |